AVTXAvalo Therapeutics, Inc.
$13.43-0.37% 1Y
$13.43
$12.7452 weeks$22.87
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Rangebound, no clear trend. Oversold (RSI 22). Price is −19% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How AVTX is trading
Avalo Therapeutics, Inc. is −0.37% over the past year while the S&P 500 is +18%: 19 points behind the market.
−0.37%
1-year return · S&P 500 +18%
- vs 200-day average
- −19%
vs 200-day average · a clear downtrend
- RSI (14)
- 22
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 41%
Below its 52-week high
Details›
- Last close2026-10-08
- $13.43
- 1 monthS&P 500 +1.6%
- −26%
- 1 yearS&P 500 +18%
- −0.37%
- 5 yearsS&P 500 +86%
- −100%
- vs 50-day average$17.74
- −24%
- 52-week high
- $22.87
- 52-week low
- $12.74
- Annualised volatility
- 86%
| Year | Return |
|---|---|
| 2026 (year to date) | −26% |
| 2025 | +144% |
| 2024 | −18% |
| 2023 | −99% |
| 2022 | −75% |
| 2021 | −36% |
| 2020 | −51% |
| 2019 | +67% |
| 2018 | +0.94% |
| 2017 | +264% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −6.3% |
| Feb | 10 | 4 of 10 | −1.5% |
| Mar | 10 | 2 of 10 | +29% |
| Apr | 10 | 2 of 10 | −10% |
| May | 10 | 4 of 10 | −1.1% |
| Jun | 10 | 8 of 10 | +3.3% |
| Jul | 11 | 5 of 11 | +2.2% |
| Aug | 11 | 7 of 11 | −2.6% |
| Sep | 11 | 6 of 11 | +2.3% |
| Oct | 11 | 6 of 11 | +14% |
| Nov | 10 | 4 of 10 | −5.1% |
| Dec | 10 | 3 of 10 | −3.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.